Synerkine Pharma appoints Industry Veteran Anders Ekblom to its Board of Directors

Synerkine Pharma today announced the appointment of industry veteran Anders Ekblom, MD, PhD, DDS as a new Member of its Board of Directors. The appointment adds a wealth of pharmaceutical industry and drug development expertise to Synerkine Pharma’s board.

Read More

Previous
Previous

Synerkine Pharma and NorthX Biologics sign manufacturing alliance

Next
Next

Synerkine Pharma secures EUR 12.1 million to accelerate novel pain therapeutics towards clinical proof-of-concept